SBIO
Fund Stats as of 07/25/2017
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $29.23
Last Trade Price $29.24
NAV $29.21
NAV Change $-0.40
Total Net Assets $121,210,109
Total Market Value $121,224,925
Premium/Discount(%) 0.07%
Difference ($) $0.02
Volume 72,831
Shares Outstanding 4,150,000
Expenses as of 03/31/2016
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Quarterly Scorecard 
Statutory Prospectus 
Resource Library  

Daily Fund Holdings 94 total, as of 07/25/2017, subject to change

SecuritySymbolWeight
Exelixis Inc.EXEL5.57%
Kite Pharma Inc.KITE4.72%
Taro Pharmaceutical Industries Ltd.TARO3.56%
Akorn Inc.AKRX3.16%
Galapagos NV Sponsored ADRGLPG3.13%
Bluebird Bio Inc.BLUE3.05%
Portola Pharmaceuticals Inc.PTLA2.84%
ACADIA Pharmaceuticals Inc.ACAD2.76%
Nektar TherapeuticsNKTR2.72%
OPKO Health Inc.OPK2.70%
Intercept Pharmaceuticals Inc.ICPT2.43%
Sage Therapeutics Inc.SAGE2.37%
Ultragenyx Pharmaceutical Inc.RARE2.26%
GW Pharmaceuticals PLCGWPH2.20%
Agios Pharmaceuticals Inc.AGIO2.11%
BeiGene Ltd.BGNE2.09%
Ligand Pharmaceuticals Inc.LGND1.94%
Endo International PLCENDP1.94%
FibroGen Inc.FGEN1.86%
Axovant Sciences Ltd.AXON1.74%
Ironwood Pharmaceuticals Inc.IRWD1.72%
Spark Therapeutics Inc.ONCE1.66%
Horizon Pharma PLCHZNP1.65%
Supernus Pharmaceuticals Inc.SUPN1.62%
DBV Technologies SA Sponsored ADRDBVT1.59%
Aerie Pharmaceuticals Inc.AERI1.49%
Loxo Oncology Inc.LOXO1.45%
Theravance Biopharma Inc.TBPH1.43%
Halozyme Therapeutics Inc.HALO1.42%
Advanced Accelerator Applications SAAAAP1.39%
Pacira Pharmaceuticals Inc.PCRX1.29%
Emergent BioSolutions Inc.EBS1.11%
Impax Laboratories Inc.IPXL1.08%
Array BioPharma Inc.ARRY1.01%
Acceleron Pharma Inc.XLRN0.94%
Global Blood Therapeutics Inc.GBT0.94%
Aimmune Therapeutics Inc.AIMT0.82%
Forward Pharma ASFWP0.80%
Acorda Therapeutics Inc.ACOR0.80%
Neuroderm Ltd.NDRM0.77%
Aduro Biotech Inc.ADRO0.72%
Ascendis Pharma AS ADRASND0.68%
Biohaven Pharmaceutical Holding Co. Ltd.BHVN0.68%
Five Prime Therapeutics Inc.FPRX0.66%
Achaogen Inc.AKAO0.61%
Aclaris Therapeutics Inc.ACRS0.59%
Flexion Therapeutics Inc.FLXN0.58%
Lannett Co. Inc.LCI0.58%
Epizyme Inc.EPZM0.56%
PTC Therapeutics Inc.PTCT0.55%
Revance Therapeutics Inc.RVNC0.54%
Enanta Pharmaceuticals Inc.ENTA0.54%
AMAG Pharmaceuticals Inc.AMAG0.53%
Depomed Inc.DEPO0.51%
Versartis Inc.VSAR0.50%
MacroGenics Inc.MGNX0.46%
NantKwest Inc.NK0.45%
Otonomy Inc.OTIC0.44%
Achillion Pharmaceuticals Inc.ACHN0.43%
SciClone Pharmaceuticals Inc.SCLN0.43%
Seres Therapeutics Inc.MCRB0.43%
Paratek Pharmaceuticals Inc.PRTK0.43%
AnaptysBio Inc.ANAB0.42%
Aurinia Pharmaceuticals IncAUPH0.40%
Akebia Therapeutics Inc.AKBA0.40%
Sucampo Pharmaceuticals Inc.SCMP0.39%
MyoKardia Inc.MYOK0.36%
Progenics Pharmaceuticals Inc.PGNX0.35%
Atara Biotherapeutics Inc.ATRA0.35%
Reata Pharmaceuticals Inc.RETA0.34%
G1 Therapeutics Inc.GTHX0.32%
Jounce Therapeutics Inc.JNCE0.32%
Avadel Pharmaceuticals PLCAVDL0.31%
Adamas Pharmaceuticals Inc.ADMS0.31%
BioCryst Pharmaceuticals Inc.BCRX0.31%
PDL BioPharma Inc.PDLI0.30%
Adaptimmune Therapeutics PLCADAP0.30%
Concert Pharmaceuticals Inc.CNCE0.27%
Aquinox Pharmaceuticals Inc.AQXP0.26%
Ra Pharmaceuticals Inc.RARX0.26%
Corbus Pharmaceuticals Holdings Inc.CRBP0.23%
Idera Pharmaceuticals Inc.IDRA0.23%
Syndax Pharmaceuticals Inc.SNDX0.22%
Minerva Neurosciences Inc.NERV0.21%
Tocagen Inc.TOCA0.17%
Zynerba Pharmaceuticals Inc.ZYNE0.17%
UroGen Pharma Ltd.URGN0.17%
Chimerix Inc.CMRX0.17%
Ovid therapeutics Inc.OVID0.16%
Ocular Therapeutix Inc.OCUL0.14%
Matinas BioPharma Holdings Inc.MTNB0.09%
Dyax Corp. - CVRDYAX-CVR0.00%
State Street Institutional Treasury Plus Money Market FundTPIXX0.05%
Cash and Equivalents-0.01%
Total Net Assets 100.00%
Security
Exelixis Inc.
Kite Pharma Inc.
Taro Pharmaceutical Industries Ltd.
Akorn Inc.
Galapagos NV Sponsored ADR
Bluebird Bio Inc.
Portola Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc.
Nektar Therapeutics
OPKO Health Inc.
Intercept Pharmaceuticals Inc.
Sage Therapeutics Inc.
Ultragenyx Pharmaceutical Inc.
GW Pharmaceuticals PLC
Agios Pharmaceuticals Inc.
BeiGene Ltd.
Ligand Pharmaceuticals Inc.
Endo International PLC
FibroGen Inc.
Axovant Sciences Ltd.
Ironwood Pharmaceuticals Inc.
Spark Therapeutics Inc.
Horizon Pharma PLC
Supernus Pharmaceuticals Inc.
DBV Technologies SA Sponsored ADR
Aerie Pharmaceuticals Inc.
Loxo Oncology Inc.
Theravance Biopharma Inc.
Halozyme Therapeutics Inc.
Advanced Accelerator Applications SA
Pacira Pharmaceuticals Inc.
Emergent BioSolutions Inc.
Impax Laboratories Inc.
Array BioPharma Inc.
Acceleron Pharma Inc.
Global Blood Therapeutics Inc.
Aimmune Therapeutics Inc.
Forward Pharma AS
Acorda Therapeutics Inc.
Neuroderm Ltd.
Aduro Biotech Inc.
Ascendis Pharma AS ADR
Biohaven Pharmaceutical Holding Co. Ltd.
Five Prime Therapeutics Inc.
Achaogen Inc.
Aclaris Therapeutics Inc.
Flexion Therapeutics Inc.
Lannett Co. Inc.
Epizyme Inc.
PTC Therapeutics Inc.
Revance Therapeutics Inc.
Enanta Pharmaceuticals Inc.
AMAG Pharmaceuticals Inc.
Depomed Inc.
Versartis Inc.
MacroGenics Inc.
NantKwest Inc.
Otonomy Inc.
Achillion Pharmaceuticals Inc.
SciClone Pharmaceuticals Inc.
Seres Therapeutics Inc.
Paratek Pharmaceuticals Inc.
AnaptysBio Inc.
Aurinia Pharmaceuticals Inc
Akebia Therapeutics Inc.
Sucampo Pharmaceuticals Inc.
MyoKardia Inc.
Progenics Pharmaceuticals Inc.
Atara Biotherapeutics Inc.
Reata Pharmaceuticals Inc.
G1 Therapeutics Inc.
Jounce Therapeutics Inc.
Avadel Pharmaceuticals PLC
Adamas Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc.
PDL BioPharma Inc.
Adaptimmune Therapeutics PLC
Concert Pharmaceuticals Inc.
Aquinox Pharmaceuticals Inc.
Ra Pharmaceuticals Inc.
Corbus Pharmaceuticals Holdings Inc.
Idera Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc.
Minerva Neurosciences Inc.
Tocagen Inc.
Zynerba Pharmaceuticals Inc.
UroGen Pharma Ltd.
Chimerix Inc.
Ovid therapeutics Inc.
Ocular Therapeutix Inc.
Matinas BioPharma Holdings Inc.
Dyax Corp. - CVR
State Street Institutional Treasury Plus Money Market Fund
Cash and Equivalents
Total Net Assets